Overview

Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
Patients with or without diabetes may have high blood sugar levels due to stress response of the body during heart surgery. This study is being done to determine if maintaining normal blood sugar levels during open-heart surgery by using intravenous insulin results in a lesser incidence of death, wound infections in the chest, disturbances of heart rhythm, kidney failure, stroke and prolonged time on the breathing machine (artificial ventilation) within 30 days after surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin